← All stories
Markets
Solvonis (LSE:SVNS) Funding Move: What Changes Now?
Highlights Solvonis has secured fresh funding to advance its CNS development pipeline. Resources will be spread across three addiction-focused therapeutic programmes. Clinical expansion and regulatory preparation now move further into focus…
Covered by 1 outlet
All coverage · 1 article